Quantitation of endogenous peptides using mass spectrometry based methods

Current Opinion in Chemical Biology

Volumn 17, Issue 5, 2013, Pages 801-808

  Romanova, Elena V ^a   Dowd, Sarah E ^a   Sweedler, Jonathan V ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ENDORPHIN; ALPHA INTERMEDIN; GAMMA ENDORPHIN; NEUROPEPTIDE Y; PEPTIDE; PHEROMONE; STABLE ISOTOPE; SUCCINIC ANHYDRIDE; TETRAXETAN;

CAENORHABDITIS ELEGANS; CHEMICAL LABELING; CORRELATION ANALYSIS; ION CYCLOTRON RESONANCE MASS SPECTROMETRY; ISOTOPE LABELING; MASS SPECTROMETRY; MEASUREMENT ACCURACY; MONITORING; NONHUMAN; PEPTIDE ANALYSIS; PEPTIDOMICS; PROTEIN DEGRADATION; QUADRUPOLE MASS SPECTROMETRY; QUANTITATIVE ANALYSIS; REVIEW; SAMPLING; SELECTED REACTION MONITORING; TANDEM MASS SPECTROMETRY; TIME OF FLIGHT MASS SPECTROMETRY;

ANIMALS; HUMANS; MASS SPECTROMETRY; PEPTIDES; PROTEOMICS; REPRODUCIBILITY OF RESULTS;

EID: 84887200580     PISSN: 13675931     EISSN: 18790402     Source Type: Journal    
DOI: 10.1016/j.cbpa.2013.05.030     Document Type: Review

References (50)

1. Hou X., Xie F., Sweedler J.V. Relative quantitation of neuropeptides over a thousand-fold concentration range. J Am Soc Mass Spectrom 2012, 23:2083-2093.
2. Kusmierz J.J., Sumrada R., Desiderio D.M. Fast atom bombardment mass spectrometric quantitative analysis of methionine-enkephalin in human pituitary tissues. Anal Chem 1990, 62:2395-2400.
3. Gygi S.P., Rist B., Gerber S.A., Turecek F., Gelb M.H., Aebersold R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol 1999, 17:994-999.
4. Larance M., Bailly A.P., Pourkarimi E., Hay R.T., Buchanan G., Coulthurst S., Xirodimas D.P., Gartner A., Lamond A.I. Stable-isotope labeling with amino acids in nematodes. Nat Methods 2011, 8:849-851.
5. Yin P., Hou X., Romanova E.V., Sweedler J.V. Neuropeptidomics: mass spectrometry-based qualitative and quantitative analysis. Methods Mol Biol 2011, 789:223-236.
6. Gelman J.S., Wardman J., Bhat V.B., Gozzo F.C., Fricker L.D. Quantitative peptidomics to measure neuropeptide levels in animal models relevant to psychiatric disorders. Methods Mol Biol 2012, 829:487-503.
7. Wardman J.H., Zhang X., Gagnon S., Castro L.M., Zhu X., Steiner D.F., Day R., Fricker L.D. Analysis of peptides in prohormone convertase 1/3 null mouse brain using quantitative peptidomics. J Neurochem 2010, 114:215-225.
8. Zhang X., Pan H., Peng B., Steiner D.F., Pintar J.E., Fricker L.D. Neuropeptidomic analysis establishes a major role for prohormone convertase-2 in neuropeptide biosynthesis. J Neurochem 2010, 112:1168-1179.
9. Gelman J.S., Sironi J., Castro L.M., Ferro E.S., Fricker L.D. Peptidomic analysis of human cell lines. J Proteome Res 2011, 10:1583-1592.
10. Gelman J.S., Dasgupta S., Berezniuk I., Fricker L.D. Analysis of peptides secreted from cultured mouse brain tissue. Biochim Biophys Acta 2013, in press, [Epub ahead of print]. 10.1016/j.bbapap.2013.01.043.
11. Rubakhin S.S., Sweedler J.V. Quantitative measurements of cell-cell signaling peptides with single-cell MALDI MS. Anal Chem 2008, 80:7128-7136.
12. Brockmann A., Annangudi S.P., Richmond T.A., Ament S.A., Xie F., Southey B.R., Rodriguez-Zas S.R., Robinson G.E., Sweedler J.V. Quantitative peptidomics reveal brain peptide signatures of behavior. Proc Natl Acad Sci U S A 2009, 106:2383-2388.
13. Miller L.K., Hou X., Rodriguiz R.M., Gagnidze K., Sweedler J.V., Wetsel W.C., Devi L.A. Mice deficient in endothelin-converting enzyme-2 exhibit abnormal responses to morphine and altered peptide levels in the spinal cord. J Neurochem 2011, 119:1074-1085.
14. Yin P., Bousquet-Moore D., Annangudi S.P., Southey B.R., Mains R.E., Eipper B.A., Sweedler J.V. Probing the production of amidated peptides following genetic and dietary copper manipulations. PLoS ONE 2011, 6:e28679.
15. Sterkel M., Urlaub H., Rivera-Pomar R., Ons S. Functional proteomics of neuropeptidome dynamics during the feeding process of Rhodnius prolixus. J Proteome Res 2011, 10:3363-3371.
16. Gregorius B., Jakoby T., Schaumloffel D., Tholey A. Metal labeling for accurate multiplexed peptide quantification via matrix-assisted laser desorption/ionization mass spectrometry. Anal Bioanal Chem 2013, 405:2735-2741.
17. Neilson K.A., Ali N.A., Muralidharan S., Mirzaei M., Mariani M., Assadourian G., Lee A., van Sluyter S.C., Haynes P.A. Less label, more free: approaches in label-free quantitative mass spectrometry. Proteomics 2011, 11:535-553.
18. Lee J.E., Zamdborg L., Southey B.R., Atkins N., Mitchell J.W., Li M., Gillette M.U., Kelleher N.L., Sweedler J.V. Quantitative peptidomics for discovery of circadian-related peptides from the rat suprachiasmatic nucleus. J Proteome Res 2013, 12:585-593.
19. Scholz B., Alm H., Mattsson A., Nilsson A., Kultima K., Savitski M.M., Falth M., Skold K., Brunstrom B., Andren P.E., et al. Neuropeptidomic analysis of the embryonic Japanese quail diencephalon. BMC Dev Biol 2010, 10.
20. Rossbach U., Nilsson A., Falth M., Kultima K., Zhou Q., Hallberg M., Gordh T., Andren P.E., Nyberg F. A quantitative peptidomic analysis of peptides related to the endogenous opioid and tachykinin systems in nucleus accumbens of rats following naloxone-precipitated morphine withdrawal. J Proteome Res 2009, 8:1091-1098.
21. Gallien S., Duriez E., Domon B. Selected reaction monitoring applied to proteomics. J Mass Spectrom 2011, 46:298-312.
22. Picotti P., Aebersold R. Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions. Nat Methods 2012, 9:555-566.
23. Kosanam H., Ramagiri S., Dass C. Quantification of endogenous alpha- and gamma-endorphins in rat brain by liquid chromatography-tandem mass spectrometry. Anal Biochem 2009, 392:83-89.
24. Perroud B., Alvarado R., Espinal G., Morado A., Phinney B., Warden C. In vivo multiplex quantitative analysis of 3 forms of alpha melanocyte stimulating hormone in pituitary of prolyl endopeptidase deficient mice. Mol Brain 2009, 2:14.
25. Xi L., Jin Y.P., Parker E.A., Josh P., Jones A., Wijffels G., Colgrave M.L. Challenges in mass spectrometry-based quantification of bioactive peptides: a case study exploring the neuropeptide Y family. Biopolymers 2012, 98:357-366.
26. Filiou M.D., Martins-de-Souza D., Guest P.C., Bahn S., Turck C.W. To label or not to label: applications of quantitative proteomics in neuroscience research. Proteomics 2012, 12:736-747.
27. Kim K.Y., Joo H.J., Kwon H.W., Kim H., Hancock W.S., Paik Y.K. Development of a method to quantitate nematode pheromone for study of small-molecule metabolism in Caenorhabditis elegans. Anal Chem 2013, 85:2681-2688.
28. Romanova E.V., Rubakhin S.S., Sweedler J.V. One-step sampling, extraction, and storage protocol for peptidomics using dihydroxybenzoic acid. Anal Chem 2008, 80:3379-3386.
29. Wang J.H., Jiang X.Y., Sturm R.M., Li L.J. Combining tissue extraction and off-line capillary electrophoresis matrix-assisted laser desorption/ionization Fourier transform mass spectrometry for neuropeptide analysis in individual neuronal organs using 2,5-dihydroxybenzoic acid as a multi-functional agent. J Chromatogr 2009, 1216:8283-8288.
30. Zhang X.Z., Petruzziello F., Zani F., Fouillen L., Andren P.E., Solinas G., Rainer G. High identification rates of endogenous neuropeptides from mouse brain. J Proteome Res 2012, 11:2819-2827.
31. Ahmed M.M., Gardiner K.J. Preserving protein profiles in tissue samples: differing outcomes with and without heat stabilization. J Neurosci Methods 2011, 196:99-106.
32. Svensson M., Boren M., Skold K., Falth M., Sjogren B., Andersson M., Svenningsson P., Andren P.E. Heat stabilization of the tissue proteome: a new technology for improved proteomics. J Proteome Res 2009, 8:974-981.
33. Gonzalez-Galarza F.F., Lawless C., Hubbard S.J., Fan J., Bessant C., Hermjakob H., Jones A.R. A critical appraisal of techniques, software packages, and standards for quantitative proteomic analysis. OMICS 2012, 16:431-442.
34. Cappadona S., Baker P.R., Cutillas P.R., Heck A.J., van Breukelen B. Current challenges in software solutions for mass spectrometry-based quantitative proteomics. Amino Acids 2012, 43:1087-1108.
35. Colaert N., Vandekerckhove J., Martens L., Gevaert K. A case study on the comparison of different software tools for automated quantification of peptides. Gel-Free Proteom Methods Protocols 2011, 753:373-398.
36. Romanova E.V., Lee J.E., Kelleher N.L., Sweedler J.V., Gulley J.M. Mass spectrometry screening reveals peptides modulated differentially in the medial prefrontal cortex of rats with disparate initial sensitivity to cocaine. AAPS J 2010, 12:443-454.
37. Romanova E.V., Lee J.E., Kelleher N.L., Sweedler J.V., Gulley J.M. Comparative peptidomics analysis of neural adaptations in rats repeatedly exposed to amphetamine. J Neurochem 2012, 123:276-287.
38. Fricker L.D. Neuropeptidomics to study peptide processing in animal models of obesity. Endocrinology 2007, 148:4185-4190.
39. Gruson D., Bodovitz S. Rapid emergence of multimarker strategies in laboratory medicine. Biomarker 2010, 15:289-296.
40. Ling X.B., Mellins E.D., Sylvester K.G., Cohen H.J. Urine peptidomics for clinical biomarker discovery. Adv Clin Chem 2010, 51:181-213.
41. Quintana L.F., Campistol J.M., Alcolea M.P., Banon-Maneus E., Sol-Gonzalez A., Cutillas P.R. Application of label-free quantitative peptidomics for the identification of urinary biomarkers of kidney chronic allograft dysfunction. Mol Cell Proteomics 2009, 8:1658-1673.
42. Pietrowska M., Polanska J., Suwinski R., Widel M., Rutkowski T., Marczyk M., Dominczyk I., Ponge L., Marczak L., Polanski A., et al. Comparison of peptide cancer signatures identified by mass spectrometry in serum of patients with head and neck, lung and colorectal cancers: association with tumor progression. Int J Oncol 2012, 40:148-156.
43. Shen Y., Tolic N., Liu T., Zhao R., Petritis B.O., Gritsenko M.A., Camp D.G., Moore R.J., Purvine S.O., Esteva F.J., et al. Blood peptidome-degradome profile of breast cancer. PLoS ONE 2010, 5:e13133.
44. Terracciano R., Preiano M., Palladino G.P., Carpagnano G.E., Barbaro M.P., Pelaia G., Savino R., Maselli R. Peptidome profiling of induced sputum by mesoporous silica beads and MALDI-TOF MS for non-invasive biomarker discovery of chronic inflammatory lung diseases. Proteomics 2011, 11:3402-3414.
45. Hansen H.G., Overgaard J., Lajer M., Hubalek F., Hojrup P., Pedersen L., Tarnow L., Rossing P., Pociot F., McGuire J.N. Finding diabetic nephropathy biomarkers in the plasma peptidome by high-throughput magnetic bead processing and MALDI-TOF-MS analysis. Proteomics Clin Appl 2010, 4:697-705.
46. Amado F., Lobo M.J., Domingues P., Duarte J.A., Vitorino R. Salivary peptidomics. Expert Rev Proteomics 2010, 7:709-721.
47. Lone A.M., Kim Y.G., Saghatelian A. Peptidomics methods for the identification of peptidase-substrate interactions. Curr Opin Chem Biol 2013, 17:83-89.
48. Gelman J.S., Sironi J., Berezniuk I., Dasgupta S., Castro L.M., Gozzo F.C., Ferro E.S., Fricker L.D. Alterations of the intracellular peptidome in response to the proteasome inhibitor bortezomib. PLoS ONE 2013, 8:e53263.
49. Tinoco A.D., Kim Y.G., Tagore D.M., Wiwczar J., Lane W.S., Danial N.N., Saghatelian A. A peptidomics strategy to elucidate the proteolytic pathways that inactivate peptide hormones. Biochemistry (Mosc) 2011, 50:2213-2222.
50. Kim Y.G., Lone A.M., Nolte W.M., Saghatelian A. Peptidomics approach to elucidate the proteolytic regulation of bioactive peptides. Proc Natl Acad Sci U S A 2012, 109:8523-8527.